Related Experiment Video
Updated: Sep 3, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Long-term outcomes in distinct phenogroups of patients with primary mitral regurgitation undergoing valve surgery
Soongu Kwak1,2, Seung-Ah Lee3, Jaehyun Lim1,2
1Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea (the Republic of).
Objectives:
Patients with mitral regurgitation (MR) may be heterogeneous with different risk profiles. We aimed to identify distinct phenogroups of patients with severe primary MR and investigate their long-term prognosis after mitral valve (MV) surgery.
Methods:
The retrospective cohort of patients with severe primary MR undergoing MV surgery (derivation, n=1629; validation, n=692) was analysed. Latent class analysis was used to classify patients into subgroups using 15 variables. The primary outcome was all-cause mortality after MV surgery.
Results:
During follow-up (median 6.0 years), 149 patients (9.1%) died in the derivation cohort. In the univariable Cox analysis, age, female, atrial fibrillation, left ventricular (LV) end-systolic dimension/volumes, LV ejection fraction, left atrial dimension and tricuspid regurgitation peak velocity were significant predictors of mortality following MV surgery. Five distinct phenogroups were identified, three younger groups (group 1-3) and two older groups (group 4-5): group 1, least comorbidities; group 2, men with LV enlargement; group 3, predominantly women with rheumatic MR; group 4, low-risk older patients; and group 5, high-risk older patients. Cumulative survival was the lowest in group 5, followed by groups 3 and 4 (5-year survival for groups 1-5: 98.5%, 96.0%, 91.7%, 95.6% and 83.4%; p<0.001). Phenogroups had similar predictive performance compared with the Mitral Regurgitation International Database score in patients with degenerative MR (3-year C-index, 0.763 vs 0.750, p=0.602). These findings were reproduced in the validation cohort.
Conclusion:
Five phenogroups of patients with severe primary MR with different risk profiles and outcomes were identified. This phenogrouping strategy may improve risk stratification when optimising the timing and type of interventions for severe MR.
Insights
Researchers identified five distinct patient groups with severe primary mitral regurgitation (MR). These phenogroups have different risk profiles and long-term outcomes after mitral valve surgery, aiding personalized treatment strategies.
Area of Science:
- Cardiology
- Medical Research
- Patient Stratification
Background:
- Severe primary mitral regurgitation (MR) presents heterogeneous patient profiles and varying risk levels.
- Understanding these differences is crucial for optimizing treatment and predicting outcomes after mitral valve (MV) surgery.
Purpose of the Study:
- To identify distinct patient phenogroups within severe primary MR.
- To investigate the long-term prognosis of these identified phenogroups following MV surgery.
Main Methods:
- Retrospective analysis of a large cohort of patients with severe primary MR undergoing MV surgery (derivation and validation sets).
- Latent class analysis using 15 clinical variables to classify patients into subgroups.
- Primary outcome assessed was all-cause mortality post-MV surgery.
Main Results:
- Five distinct phenogroups were identified: three younger (varying comorbidities and demographics) and two older (low-risk and high-risk).
- Significant differences in cumulative survival were observed among phenogroups, with the highest mortality in the high-risk older group (83.4% 5-year survival).
- The identified phenogroups demonstrated comparable predictive performance to existing scores for degenerative MR.
Conclusions:
- The study successfully delineated five phenogroups for severe primary MR patients, each with unique risk profiles and prognoses.
- This phenogrouping approach offers a potential improvement in risk stratification for optimizing surgical timing and intervention strategies in MR patients.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation IV: Nursing Management
Mitral Valve Prolapse I: Introduction

